Global Malaria Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301010273 | Category: Pharma & Healthcare | Pages: 100 | Format: PDF | Published Date: February 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Malaria Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Malaria Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Malaria Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Malaria Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Malaria Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Malaria Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Malaria Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Malaria Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline and Mylan Labs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Malaria Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Aryl Aminoalcohol Compounds
    Antifolate Compounds
    Artemisinin Compounds
Market segment by Application
    Prevention
    Treatment
    Other
Major players covered
    Cipla
    Guilin Pharmaceutical
    IPCA Laboratories
    GlaxoSmithKline
    Mylan Labs
    Roche
    Novartis
    Sanofi Aventis
    Ajanta Pharma
    Kunming Pharmaceutical
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Malaria Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Malaria Drugs, with price, sales, revenue and global market share of Malaria Drugs from 2018 to 2023.
Chapter 3, the Malaria Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Malaria Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Malaria Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Malaria Drugs.
Chapter 14 and 15, to describe Malaria Drugs sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Malaria Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Malaria Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Aryl Aminoalcohol Compounds
        1.3.3 Antifolate Compounds
        1.3.4 Artemisinin Compounds
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Malaria Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Prevention
        1.4.3 Treatment
        1.4.4 Other
    1.5 Global Malaria Drugs Market Size & Forecast
        1.5.1 Global Malaria Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Malaria Drugs Sales Quantity (2018-2029)
        1.5.3 Global Malaria Drugs Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Cipla
        2.1.1 Cipla Details
        2.1.2 Cipla Major Business
        2.1.3 Cipla Malaria Drugs Product and Services
        2.1.4 Cipla Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Cipla Recent Developments/Updates
    2.2 Guilin Pharmaceutical
        2.2.1 Guilin Pharmaceutical Details
        2.2.2 Guilin Pharmaceutical Major Business
        2.2.3 Guilin Pharmaceutical Malaria Drugs Product and Services
        2.2.4 Guilin Pharmaceutical Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Guilin Pharmaceutical Recent Developments/Updates
    2.3 IPCA Laboratories
        2.3.1 IPCA Laboratories Details
        2.3.2 IPCA Laboratories Major Business
        2.3.3 IPCA Laboratories Malaria Drugs Product and Services
        2.3.4 IPCA Laboratories Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 IPCA Laboratories Recent Developments/Updates
    2.4 GlaxoSmithKline
        2.4.1 GlaxoSmithKline Details
        2.4.2 GlaxoSmithKline Major Business
        2.4.3 GlaxoSmithKline Malaria Drugs Product and Services
        2.4.4 GlaxoSmithKline Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 GlaxoSmithKline Recent Developments/Updates
    2.5 Mylan Labs
        2.5.1 Mylan Labs Details
        2.5.2 Mylan Labs Major Business
        2.5.3 Mylan Labs Malaria Drugs Product and Services
        2.5.4 Mylan Labs Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Mylan Labs Recent Developments/Updates
    2.6 Roche
        2.6.1 Roche Details
        2.6.2 Roche Major Business
        2.6.3 Roche Malaria Drugs Product and Services
        2.6.4 Roche Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Roche Recent Developments/Updates
    2.7 Novartis
        2.7.1 Novartis Details
        2.7.2 Novartis Major Business
        2.7.3 Novartis Malaria Drugs Product and Services
        2.7.4 Novartis Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Novartis Recent Developments/Updates
    2.8 Sanofi Aventis
        2.8.1 Sanofi Aventis Details
        2.8.2 Sanofi Aventis Major Business
        2.8.3 Sanofi Aventis Malaria Drugs Product and Services
        2.8.4 Sanofi Aventis Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sanofi Aventis Recent Developments/Updates
    2.9 Ajanta Pharma
        2.9.1 Ajanta Pharma Details
        2.9.2 Ajanta Pharma Major Business
        2.9.3 Ajanta Pharma Malaria Drugs Product and Services
        2.9.4 Ajanta Pharma Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Ajanta Pharma Recent Developments/Updates
    2.10 Kunming Pharmaceutical
        2.10.1 Kunming Pharmaceutical Details
        2.10.2 Kunming Pharmaceutical Major Business
        2.10.3 Kunming Pharmaceutical Malaria Drugs Product and Services
        2.10.4 Kunming Pharmaceutical Malaria Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Kunming Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Malaria Drugs by Manufacturer
    3.1 Global Malaria Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Malaria Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global Malaria Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Malaria Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Malaria Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 Malaria Drugs Manufacturer Market Share in 2022
    3.5 Malaria Drugs Market: Overall Company Footprint Analysis
        3.5.1 Malaria Drugs Market: Region Footprint
        3.5.2 Malaria Drugs Market: Company Product Type Footprint
        3.5.3 Malaria Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Malaria Drugs Market Size by Region
        4.1.1 Global Malaria Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global Malaria Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global Malaria Drugs Average Price by Region (2018-2029)
    4.2 North America Malaria Drugs Consumption Value (2018-2029)
    4.3 Europe Malaria Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific Malaria Drugs Consumption Value (2018-2029)
    4.5 South America Malaria Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa Malaria Drugs Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Malaria Drugs Sales Quantity by Type (2018-2029)
    5.2 Global Malaria Drugs Consumption Value by Type (2018-2029)
    5.3 Global Malaria Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Malaria Drugs Sales Quantity by Application (2018-2029)
    6.2 Global Malaria Drugs Consumption Value by Application (2018-2029)
    6.3 Global Malaria Drugs Average Price by Application (2018-2029)
7 North America
    7.1 North America Malaria Drugs Sales Quantity by Type (2018-2029)
    7.2 North America Malaria Drugs Sales Quantity by Application (2018-2029)
    7.3 North America Malaria Drugs Market Size by Country
        7.3.1 North America Malaria Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America Malaria Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Malaria Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe Malaria Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe Malaria Drugs Market Size by Country
        8.3.1 Europe Malaria Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe Malaria Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Malaria Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Malaria Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Malaria Drugs Market Size by Region
        9.3.1 Asia-Pacific Malaria Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Malaria Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Malaria Drugs Sales Quantity by Type (2018-2029)
    10.2 South America Malaria Drugs Sales Quantity by Application (2018-2029)
    10.3 South America Malaria Drugs Market Size by Country
        10.3.1 South America Malaria Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America Malaria Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Malaria Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Malaria Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Malaria Drugs Market Size by Country
        11.3.1 Middle East & Africa Malaria Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Malaria Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Malaria Drugs Market Drivers
    12.2 Malaria Drugs Market Restraints
    12.3 Malaria Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Malaria Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Malaria Drugs
    13.3 Malaria Drugs Production Process
    13.4 Malaria Drugs Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Malaria Drugs Typical Distributors
    14.3 Malaria Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Malaria Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?